Ovoca Bio Plc Logo

Ovoca Bio Plc

Biopharma developing a novel therapy for premenopausal women with low sexual desire (HSDD).

OVXA | IR

Overview

Corporate Details

ISIN(s):
IE0006649010 (+1 more)
LEI:
213800ST2AK5XQ1O5207
Country:
Ireland
Address:
17 PEMBROKE STREET UPPER, D02 AT22 DUBLIN
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ovoca Bio Plc is a clinical-stage biopharmaceutical company focused on developing novel treatments for women's health. The company's lead product candidate is Orenetide, a medicinal therapy for premenopausal women with hypoactive sexual desire disorder (HSDD), a condition with significant unmet medical need. Ovoca Bio is advancing Orenetide through clinical development and regulatory approval processes in the US, Europe, and other major global markets. The company's strategy involves leveraging its protective patent portfolio and seeking commercialization through licensing agreements and collaborations with pharmaceutical partners.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-12-01 13:00
Result of AGM
English 7.8 KB
2023-11-07 10:15
Notice of AGM
English 8.3 KB
2023-09-28 08:00
Interim Results
English 9.5 KB
2023-08-31 08:00
Summary Results of Phase II Study for Orenetide
English 11.7 KB
2023-06-30 08:00
Annual Financial Report
English 18.1 KB
2023-06-12 08:00
Update on Completion Timelines for Phase II Study
English 10.1 KB
2023-03-16 17:35
Price Monitoring Extension
English 2.8 KB
2023-03-16 15:05
Second Price Monitoring Extn
English 2.8 KB
2023-03-16 15:00
Price Monitoring Extension
English 2.8 KB
2023-03-16 10:05
Second Price Monitoring Extn
English 2.8 KB
2023-03-16 10:00
Price Monitoring Extension
English 2.8 KB
2023-03-08 08:00
Disposal of Russian Assets
English 13.3 KB
2023-02-14 17:41
Second Price Monitoring Extn
English 2.8 KB
2023-02-14 17:35
Price Monitoring Extension
English 2.8 KB
2023-02-14 15:05
Second Price Monitoring Extn
English 2.8 KB

Automate Your Workflow. Get a real-time feed of all Ovoca Bio Plc filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ovoca Bio Plc

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ovoca Bio Plc via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
Developing AAV-based cell and gene therapies for serious and rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom
ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France
ABNX
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France
ABVX
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France
ABLD
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden
ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Develops and commercializes innovative therapies for CNS disorders and rare diseases.
United States of America
ACAD

Talk to a Data Expert

Have a question? We'll get back to you promptly.